(Circulation. 1997;95:1954-1960.)
© 1997 American Heart Association, Inc.
Articles |
Calcifying Subpopulation of Bovine Aortic Smooth Muscle Cells Is Responsive to 17ß-Estradiol
From the Division of Cardiology, Departments of Medicine and Physiology, UCLA School of Medicine, Los Angeles, Calif.
Background Arterial calcification, common in atherosclerosis, is associated with an increased risk of clinical events such as myocardial infarction. We previously identified a subpopulation of bovine aortic medial cells, calcifying vascular cells (CVCs), that have osteoblastic characteristics and form bone mineral in vitro in the form of calcified nodules. To assess whether estrogen modulates arterial calcification as well as bone calcification, we tested CVCs for estrogen receptors and for the effect of 17ß-estradiol on formation of calcified nodules, calcium content, alkaline phosphatase activity, and osteocalcin concentration in the culture medium.
Methods and Results Estrogen receptor immunoreactivity was identified in the cytoplasm and the perinuclear region of CVCs by immunocytochemistry. CVCs were treated with 17ß-estradiol at concentrations of 0, 5, and 10 nmol/L. Twenty-one days of 17ß-estradiol treatment resulted in a significantly increased number of calcified nodules, visualized by von Kossa staining, as well as increased calcium content of the cultures. Increases in alkaline phosphatase activity, a marker for early osteoblastic differentiation, and secreted osteocalcin, a marker for late osteoblastic differentiation, were enhanced in cells treated with 17ß-estradiol compared with control cells.
Conclusions These results suggest that 17ß-estradiol promotes osteoblastic differentiation and calcification in vascular cells and that estrogen may play a regulatory role in arterial calcification.
Key Words: calcium • hormones • atherosclerosis
This article has been cited by other articles:
 |
|
 |
|
  L. McRobb, D. J. Handelsman, and A. K. Heather Androgen-Induced Progression of Arterial Calcification in Apolipoprotein E-Null Mice Is Uncoupled from Plaque Growth and Lipid Levels Endocrinology, February 1, 2009; 150(2): 841 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Rzewuska-Lech, M. Jayachandran, L. A. Fitzpatrick, and V. M. Miller Differential effects of 17{beta}-estradiol and raloxifene on VSMC phenotype and expression of osteoblast-associated proteins Am J Physiol Endocrinol Metab, July 1, 2005; 289(1): E105 - E112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Collin-Osdoby Regulation of Vascular Calcification by Osteoclast Regulatory Factors RANKL and Osteoprotegerin Circ. Res., November 26, 2004; 95(11): 1046 - 1057. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Doherty, L. A. Fitzpatrick, D. Inoue, J.-H. Qiao, M. C. Fishbein, R. C. Detrano, P. K. Shah, and T. B. Rajavashisth Molecular, Endocrine, and Genetic Mechanisms of Arterial Calcification Endocr. Rev., August 1, 2004; 25(4): 629 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Abedin, Y. Tintut, and L. L. Demer Vascular Calcification: Mechanisms and Clinical Ramifications Arterioscler Thromb Vasc Biol, July 1, 2004; 24(7): 1161 - 1170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Fitzpatrick, R. T. Turner, and E. R. Ritman Endochondral Bone Formation in the Heart: A Possible Mechanism of Coronary Calcification Endocrinology, June 1, 2003; 144(6): 2214 - 2219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Shioi, M. Katagi, Y. Okuno, K. Mori, S. Jono, H. Koyama, and Y. Nishizawa Induction of Bone-Type Alkaline Phosphatase in Human Vascular Smooth Muscle Cells: Roles of Tumor Necrosis Factor-{alpha} and Oncostatin M Derived From Macrophages Circ. Res., July 12, 2002; 91(1): 9 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Jian, P. L. Jones, Q. Li, E. R. Mohler III, F. J. Schoen, and R. J. Levy Matrix Metalloproteinase-2 Is Associated with Tenascin-C in Calcific Aortic Stenosis Am. J. Pathol., July 1, 2001; 159(1): 321 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Mohler III, F. Gannon, C. Reynolds, R. Zimmerman, M. G. Keane, and F. S. Kaplan Bone Formation and Inflammation in Cardiac Valves Circulation, March 20, 2001; 103(11): 1522 - 1528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Speir, Z.-X. Yu, K. Takeda, V. J. Ferrans, and R. O. Cannon III Competition for p300 Regulates Transcription by Estrogen Receptors and Nuclear Factor-{kappa}B in Human Coronary Smooth Muscle Cells Circ. Res., November 24, 2000; 87(11): 1006 - 1011. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. ROSTAND Coronary Heart Disease in Chronic Renal Insufficiency: Some Management Considerations J. Am. Soc. Nephrol., October 1, 2000; 11(10): 1948 - 1956. [Full Text]
|
|
|
|
 |
|
 D. C. Graves and Z. Yablonka–Reuveni Vascular Smooth Muscle Cells Spontaneously Adopt a Skeletal Muscle Phenotype: A Unique Myf5-/MyoD+ Myogenic Program J. Histochem. Cytochem., September 1, 2000; 48(9): 1173 - 1194. [Abstract] [Full Text]
|
|
|
|
|
|
S. Chanda, C. L. Robinette, J. F. Couse, and R. C. Smart 17beta -Estradiol and ICI-182780 regulate the hair follicle cycle in mice through an estrogen receptor-alpha pathway Am J Physiol Endocrinol Metab, February 1, 2000; 278(2): E202 - E210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Mori, A. Shioi, S. Jono, Y. Nishizawa, and H. Morii Dexamethasone Enhances In Vitro Vascular Calcification by Promoting Osteoblastic Differentiation of Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, September 1, 1999; 19(9): 2112 - 2118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Makela, H. Savolainen, E. Aavik, M. Myllarniemi, L. Strauss, E. Taskinen, J.-A. Gustafsson, and P. Hayry Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta PNAS, June 8, 1999; 96(12): 7077 - 7082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Wada, M. D. McKee, S. Steitz, and C. M. Giachelli Calcification of Vascular Smooth Muscle Cell Cultures : Inhibition by Osteopontin Circ. Res., February 5, 1999; 84(2): 166 - 178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Bostrom, D. Tsao, S. Shen, Y. Wang, and L. L. Demer Matrix GLA Protein Modulates Differentiation Induced by Bone Morphogenetic Protein-2 in C3H10T1/2 Cells J. Biol. Chem., April 20, 2001; 276(17): 14044 - 14052. [Abstract] [Full Text] [PDF]
|
|